ADESANTE
Vantaa
About ADESANTE
ADESANTE provides IT solutions to the healthcare. Its main product is SurgeryVision, which is a surgery planning tool for surgeons. Surgeons uses SurgeryVision for planning their surgical procedurs. SurgeryVision presents MRI / CT images to the surgeon in Virtual Reality (VR), where surgeons can make their surgical procedure planning. This plan is then presented in the OR, while operating. This helps surgeons to reduce OR time, near miss events, surgical failures and even re-operations. SurgeryVision is sold through our distributor network in Europe, Middle-East and South-East Asia and it is in use by University hospitals (in several surgical disciplines, from microsurgery to compalicated trauma surgery). Our vision is "No surgical failures", which we aim to receive by providing the surgery planning tool for all fully autonomous robotic surgery. On our way towards this ambitious goal, we have now selected as an official partner of NVIDIA Clara Inception program (among with 800 other companies globally). This would provide us a solid platform to take a next step in our path towards our goal. We also have another helathcare IT solutions in our portfolio, like therapy videos in VR and Virtual training centre. These (especially that Virtual training centre) seems to raise a lot of customer interest especially now in days of COVID-19 pandemia. By this solution it is possible to execute e.g. basic ICU nursing tasks for getting care personnel better trained for taking care of ICU patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $824.6K
- Funding stage: Seed
- Last round: Seed (Sep 2019)
- Website: surgeryvision.com
- Phone: [email protected]
Industries & Categories
Education, Health Care, Software, Virtual Reality
Social Profiles
Canonical: https://fsome.com/organization/adesante-142033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.